INOTEK PHARMACEUTICALS CORP — Form D/A
INOTEK PHARMACEUTICALS CORP of LEXINGTON, MA, a company, filed a Form D amendment with the SEC on 2011-07-19. The offering totals $23.6M, of which $23.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-07-19
- Form: D/A
- Accession: 0001281895-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $23.6M
- Amount sold: $23.6M
- Investors: 11
- Date of first sale: 2010-06-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-143912
Issuer
- Name: INOTEK PHARMACEUTICALS CORP
- CIK: 0001281895
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 33 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Phone: 781-676-2100
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Ittai N Harel | Director | Lexington, MA |
| Paul G Howes | Director | Belleville, PA |
| "Argeris (""Jerry"")" N Karabelas, PhD | Director | Lexington, MA |
| John N Leaman | Director | Lexington, MA |
| Michael D Loberg, PhD | Director | Lexington, MA |
| Atul N Saran | Director | Lexington, MA |
| Martin N Vogelbaum | Director | Lexington, MA |
| Rudolf A Baumgartner, MD | Executive Officer | Lexington, MA |
| James G Ham, III | Executive Officer | Lexington, MA |
| Paul G Howes | Executive Officer | Belleville, PA |
| William K McVicar, Ph.D. | Executive Officer | Lexington, MA |
| Ittai Flanagan Harel | Director | Lexington, MA |
| Maggie Flanagan LeFlore, PhD | Director | Lexington, MA |
| John Flanagan Leaman | Director | Lexington, MA |
Other filings by this issuer (1)
More